title: Transfemoral endovascular stented graft treatment of aorto-iliac and femoropopliteal occlusive disease for limb salvage.
abstract: BACKGROUND
  Endovascular stented grafts employ a new technique that blends intravascular stent and prosthetic graft technologies. These devices may be used to treat arterial aneurysms, occlusive disease, and vascular injuries. This report describes the application of stented grafts to the treatment of limb-threatening ischemia secondary to occlusive disease of the aorta, iliac, and femoral arteries.
  
  
  METHODS
  Three patients with limb-threatening ischemia and severe comorbid medical illnesses were treated with transvascular stented grafts that were composed of 6-mm thin-walled polytetrafluoroethylene grafts and Palmaz balloon expandable stents. The grafts were inserted through a cutdown in an artery remote from the site of occlusion and introduced into the vascular system within 14-Fr introducer sheaths.
  
  
  RESULTS
  Technical success was documented in all three patients with restoration of arterial continuity following stent graft deployment. Patency and limb salvage has been achieved to 1 year. One patient required further dilatation of the proximal stent at 6 weeks. Complications were limited to an iliofemoral deep vein thrombosis in one patient.
  
  
  CONCLUSIONS
  Endovascular stented grafts can be inserted to treat limb-threatening ischemia. Although these initial results are encouraging, greater experience in more patients observed for longer periods of time is necessary before this technique can be advocated for widespread use.
authors.affiliation: Department of Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York.
authors.forename: M L
authors.initials: ML
authors.lastname: Marin
authors.forename: F J
authors.initials: FJ
authors.lastname: Veith
authors.forename: J
authors.initials: J
authors.lastname: Cynamon
authors.forename: L A
authors.initials: LA
authors.lastname: Sanchez
authors.forename: K R
authors.initials: KR
authors.lastname: Wengerter
authors.forename: M L
authors.initials: ML
authors.lastname: Schwartz
authors.forename: J C
authors.initials: JC
authors.lastname: Parodi
authors.forename: T F
authors.initials: TF
authors.lastname: Panetta
authors.forename: C W
authors.initials: CW
authors.lastname: Bakal
authors.forename: W D
authors.initials: WD
authors.lastname: Suggs
mesh_terms: D001018:Aortic Diseases / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D001807:Blood Vessel Prosthesis; D002404:Catheterization / Q000295:instrumentation / Q000379:methods*; D003131:Combined Modality Therapy; D005263:Femoral Artery / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D005734:Gangrene; D006801:Humans; D007511:Ischemia / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D007866:Leg / Q000098:blood supply*; D011138:Polytetrafluoroethylene; D011150:Popliteal Artery / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D011183:Postoperative Complications; D011859:Radiography; D015607:Stents; D014654:Vascular Patency
chemical_list: D011138:Polytetrafluoroethylene